Updates are available Correction dated 2022-07-05
Click to view Correction: https://doi.org/10.1186/s13063-022-06484-6
-
Authors
Nemis-White, Joanna M. https://orcid.org/0000-0002-7432-8805
Hamilton, Laura M.
Shaw, Sarah
MacKillop, James H.
Parkash, Ratika
Choudhri, Shurjeel H.
Ciaccia, Antonio
Xie, Feng
Thabane, Lehana
Cox, Jafna L.
,
-
Funding
Funding for this research was provided by:
Bayer Canada
- License Information
-
More Information
Article History
Received: 29 September 2020
Accepted: 26 July 2021
First Online: 11 August 2021
Change Date: 5 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-022-06484-6
Declarations
:
: Ethics approval was granted by the Nova Scotia Health Authority Research Ethics Board (NSHA REB ROMEO FILE #: 100240). All patient participants provided written informed consent.
: Not applicable.
: J. C. reports grants from Bayer Inc. during the conduct of the study and personal fees from Bayer, Servier, and HLS Therapeutic, outside the submitted work. R.P. reports grants from Bayer and Pfizer during the conduct of the study. J.M.K. reports other fees from Merck Canada, Bayer, and Pfizer outside the submitted work. A.C. and S.H.C. are employees of Bayer Inc. J.N.W. reports personal fees from Nova Scotia Health Authority during the conduct of the study. All other authors declare no competing interests.
